Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.

Björnson E, Adiels M, Gummesson A, Taskinen MR, Burgess S, Packard CJ, Borén J.

Open source

DOI
10.1016/j.jacc.2024.07.034
Published
2024-10-01
Container
J Am Coll Cardiol
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jacc.2024.07.034,
  title = {Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.},
  author = {Björnson E and  Adiels M and  Gummesson A and  Taskinen MR and  Burgess S and  Packard CJ and  Borén J.},
  year = {2024},
  journal = {J Am Coll Cardiol},
  doi = {10.1016/j.jacc.2024.07.034},
  url = {https://doi.org/10.1016/j.jacc.2024.07.034}
}

RIS

TY  - JOUR
TI  - Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.
AU  - Björnson E
AU  -  Adiels M
AU  -  Gummesson A
AU  -  Taskinen MR
AU  -  Burgess S
AU  -  Packard CJ
AU  -  Borén J.
PY  - 2024
JO  - J Am Coll Cardiol
DO  - 10.1016/j.jacc.2024.07.034
UR  - https://doi.org/10.1016/j.jacc.2024.07.034
ER  - 

APA

E, B., M, A., A, G., MR, T., S, B., CJ, P., & J., B. (2024). Quantifying Triglyceride-Rich Lipoprotein Atherogenicity, Associations With Inflammation, and Implications for Risk Assessment Using Non-HDL Cholesterol.. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2024.07.034

Source records